Morgan Stanley’s Medovex Corp. Common Stock MDVX Stock Holding History

Morgan Stanley’s Portfolio MDVX Stock Details MDVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-17	Closed	–	–	6807
2016 Q1	$0	Sell	17 -2	-11%	-$2	﹤0.01%	6863
2015 Q4	$0	Buy	+19	New	+$30	﹤0.01%	6929
2015 Q3	–	Sell	-19	Closed	–	–	6847
2015 Q2	$0	Buy	+19	New	+$75	﹤0.01%	6858

Other funds holding MDVX

MIC

Meridian Investment Counsel Lafayette, California $466M AUM 42.29% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MHS

M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley's MDVX Position: Q2 2016 in Review

Morgan Stanley sold out of Medovex Corp. Common Stock (MDVX) in Q2 2016, closing a stake of 17 shares.

Morgan Stanley first reported a position in MDVX in Q2 2015 and held it in 3 quarters. The position peaked at $0 in Q1 2016. 10 funds tracked by Wall St. Rank hold MDVX as of Q2 2016.

Morgan Stanley reported no remaining Medovex Corp. Common Stock position as of Q2 2016 after selling out during the quarter.
Morgan Stanley sold 17 Medovex Corp. Common Stock shares in Q2 2016.
Morgan Stanley first reported a position in Medovex Corp. Common Stock in Q2 2015 and held it in 3 quarters.
Morgan Stanley's Medovex Corp. Common Stock position peaked at $0 in Q1 2016.
10 funds tracked by Wall St. Rank held Medovex Corp. Common Stock as of Q2 2016.

Based on Morgan Stanley's 13F filing for Q2 2016, filed 12 Aug 2016.